- Market Capitalization, $K 637,097
- Shares Outstanding, K 224,330
- Annual Sales, $ 191,440 K
- Annual Income, $ -542,590 K
- 60-Month Beta 2.86
- Price/Sales 2.84
- Price/Cash Flow N/A
- Price/Book 0.31
|Period||Period Low||Period High||Performance|
| || |
-0.59 (-16.67%)since 04/14/22
| || |
-1.75 (-37.23%)since 02/16/22
| || |
-3.91 (-57.00%)since 05/14/21
Aurora just "beat" on sales -- but its losses this past quarter were mind-boggling.
ACB earnings call for the period ending March 31, 2022.
Surging inflation and the Fed’s hawkish monetary policy stance could keep the stock market under pressure in the near term. Amid the uncertainties surrounding the economy and the stock market, Stifel...
Evolus, Inc. (EOLS) delivered earnings and revenue surprises of 34.15% and 12.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of 3.32% and 5.32%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Investors in Aurora Cannabis Inc saw new options become available this week, for the June 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACB options chain...
ACB stock's average consensus price target represents a 60.74% change from the last price of $3.24
Investors in Aurora Cannabis Inc saw new options begin trading this week, for the December 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time...
Profitability seems to be a long way off for Canadian cannabis companies.
Inflation, rising interest rates, and increasing geopolitical risks will keep pressuring profitless ACB stock
|Aurora Cannabis Inc|
|Global X Cannabis ETF|
|ETFMG Alternative Harvest ETF|
|Sofi 50 ETF|
|FTSE RAFI Dev Markets Ex-U.S. Small-Mid Invesco|
|FTSE All-World Ex-US Smcp Idx ETF Vanguard|